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Abstract
Recent advances have led to an understanding that the hippocampus is involved more broadly than
explicit or declarative memory alone. Tasks which involve the acquisition of complex associations
involve the hippocampus whether the learning is explicit or implicit. One hippocampal-dependent
implicit task is transitive inference (TI). Recently it was suggested that implicit transitive inference
does not depend upon the hippocampus (Frank, M. J., O'Reilly, R. C., & Curran, T. 2006. When
memory fails, intuition reigns: midazolam enhances implicit inference in humans. Psychological
Science, 17, 700–707). The authors demonstrated that intravenous midazolam, which is thought to
inactivate the hippocampus, may enhance TI performance. Three critical assumptions are required
but not met: 1) that deactivations of other regions could not account for the effect 2) that
intravenous midazolam does indeed deactivate the hippocampus and 3) that midazolam influences
explicit but not implicit memory. Each of these assumptions is seriously flawed. Consequently, the
suggestion that implicit TI does not depend upon the hippocampus is unfounded.
Introduction
The capacity to learn complex stimulus relations and
express them flexibly is thought to require the hippocam-
pus [1]. While the hippocampus has been thought to be
necessary for explicit but not implicit forms of learning
and memory [2], more recent studies demonstrate hip-
pocampal involvement in implicit tasks which require
complex associations [3-8]. One task which involves both
the acquisition of complex relations, flexible expression
and which may be learned implicitly is the transitive infer-
ence task [8-13]. At study, participants learn complex rela-
tions among stimuli (e.g., A>B, B>C, C>D, D>E) and at
test, they show flexible expression when an untrained dis-
crimination (B?D) is correctly solved (B>D). Functional
imaging studies confirm the role of the hippocampus in
both implicit and explicit versions of TI [8,14-16] and,
amnesic patients with damage to the hippocampus and
surrounding tissue cannot perform the TI task [17].
A recent study demonstrated that the administration of
intravenous midazolam improved TI performance in
human participants [18] which was argued as evidence
that TI is performed more easily when the hippocampus
does not contribute explicit strategies. The authors argue
that midazolam deactivates the hippocampus because
benzodiazepines act on GABA-A receptors [19], which are
densely concentrated in the hippocampus [20], and
because benzodiazepines – in particular midazolam –
temporarily impair explicit memory formation [21]. The
assertion that intravenous midazolam improves TI per-
formance by deactivating the hippocampus depends
entirely upon three premises: 1) that other areas critical to
TI are not affected, so that only hippocampal deactivation
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can explain the effect; 2) that midazolam deactivates the
hippocampus to the point that it no longer functions in a
mnemonic capacity; and 3) That midazolam influences
explicit but not implicit memory. There are serious prob-
lems with all three premises, each of which jeopardize the
claim that TI is performed more easily without the hip-
pocampus [18].
Discussion
In studies where midazolam has been shown to have
selective effects on the hippocampus, non-human ani-
mals receive midazolam as a direct injection into the hip-
pocampal tissue [22]. The principle action of midazolam
is as a central nervous-system depressant, which is fre-
quently used medicinally as a sedative or as an anti-con-
vulsant. While midazolam may be useful as a reversible
lesion when injected directly into the hippocampus, it is
not at all clear that the effects are comparable when it is
injected intravenously. One might expect the action of
midazolam to be much less circumscribed when it is dis-
tributed globally. Indeed, midazolam has been shown to
decrease regional cerebral blood flow (rCBF) to numerous
cortical areas other than the hippocampus or surrounding
cortices [23]. Thus, it is entirely possible that the effects of
midazolam on the TI task are attributable to deactivations
of areas other than the hippocampus.
Of the regions shown in human imaging studies to be
deactivated by normal concentrations of intravenous
midazolam, the hippocampus is not among them. Two
studies attempting to discover an effect of midazolam on
rCBF in the hippocampus found no such effects [23,24].
Clearly, failure to detect an effect of midazolam on the
rCBF of the hippocampus does not imply the effects do
not exist. However, given a compromised hippocampus
can still mediate hippocampal-dependent tasks [25] the
burden of proof must be upon those who claim that intra-
venous midazolam anesthetizes the hippocampus to the
extent that it does not function effectively in a mnemonic
capacity. Moreover, a third study varied the concentration
of intravenous midazolam and showed a global anesthe-
tizing effect at very high dosages to which the hippocam-
pus and parahippocampal regions were particularly
resistant compared to other regions of cortex [26]. It
would, therefore, strain credibility to argue that the effects
of intravenous midazolam on the hippocampus account
for its amnesic effects but simply do not reach significance
when measured by rCBF.
Furthermore, were it the case that midazolam selectively
deactivates the hippocampus, one would expect the
effects of midazolam on TI [18] to yield performance lev-
els comparable to those observed in amnesic patients, but
quite the contrary, amnesics are profoundly impaired on
the TI task [17]. It is unclear from amnesic performance
whether their inability to perform the inference portion of
the task was predicated by their inability to acquire the
premise pairs [17]. That is, amnesics do not reliably learn
that B>C and C>D and that alone could account for their
inability to make the correct inference B>D. While the
amnesic data do not therefore allow strong conclusions
about performance on just the inference portion of the
task, they do tend to disconfirm the hypothesis that
"midazolam should improve TI test performance by pre-
venting participants from memorizing the stimulus pairs
and encouraging greater implicit learning of reinforce-
ment value" [[18] p. 701]. Furthermore, performance dif-
ferences between hippocampal amnesia and midazolam-
induced amnesia provide further evidence that the effects
of intravenous midazolam are unlikely to constitute a hip-
pocampal deactivation.
Given the widespread effects of intravenous midazolam in
regions of cortex other than the hippocampus, it is natural
to question whether the effects of midazolam are limited
to explicit memory. Several studies show that midazolam
influences not just explicit, but also implicit memory per-
formance [27,28]. While implicit memory is not as pro-
foundly affected as explicit memory – indeed, explicit
performance drops to chance levels – it is nevertheless
incorrect to assert that intravenous midazolam does not
affect implicit performance.
Conclusion
The existing data do not permit claims about selective
effects if intravenous midazolam on the human hippoc-
ampus. Rather, the effects of intravenous midazolam
involve numerous regions of cortex, including frontal and
parietal regions. The assertion that intravenous mida-
zolam selectively deactivates the hippocampus is at best
premature and is more likely to be incorrect. Therefore,
there is no adequate substantiation for the claim that TI is
improved by hippocampal deactivation [18].
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